INVOLVEMENT OF METABOTROPIC GLUTAMATE RECEPTOR MGLU5 IN PUDENDAL INHIBITION OF BLADDER OVERACTIVITY IN CATS

被引：0
|
作者：
Larson, Jeffrey
Ogagan, P. Dafe
Wang, Jicheng
Shen, Bing
Roppolo, James
Tai, Changfeng
de Groat, William C.
机构：
来源：
JOURNAL OF UROLOGY | 2012年 / 187卷 / 04期
关键词：
D O I：
10.1016/j.juro.2012.02.310
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
253
引用
收藏
页码：E102 / E103
页数：2
相关论文
共 50 条
  • [31] INHIBITION OF BLADDER OVERACTIVITY BY TRANSCUTANEOUS STIMULATION TARGETING THE PUDENDAL NERVE IN CATS
    Wang, J.
    Shen, B.
    Liu, H.
    Subbaroyan, J.
    Roppolo, J.
    DeGroat, W.
    Tai, C.
    NEUROUROLOGY AND URODYNAMICS, 2009, 28 (07) : 804 - 804
  • [32] Metabotropic glutamate receptor subtype 5 (mGlu5) and nociceptive function I. Selective blockade of mGlu5 receptors in models of acute, persistent and chronic pain
    Walker, K
    Bowes, M
    Panesar, M
    Davis, A
    Gentry, C
    Kesingland, A
    Gasparini, F
    Spooren, W
    Stoehr, N
    Pagano, A
    Flor, PJ
    Vranesic, I
    Lingenhoehl, K
    Johnson, EC
    Varney, M
    Urban, L
    Kuhn, R
    NEUROPHARMACOLOGY, 2001, 40 (01) : 1 - 9
  • [33] Dysfynctions of Metabotropic Glutamate Receptor Subtype 5 (mGlu5) Receptors in a Mouse Model of Fragile X Syndrome
    Catania, M. V.
    Spatuzza, M.
    Aloisi, E.
    D'Antoni, S.
    Dupuis, J. P.
    Costa, L.
    Bonaccorso, C. M.
    Molinaro, G.
    Battaglia, G.
    Musumeci, S. A.
    Davidovic, L.
    Bardoni, B.
    Ciranna, L.
    Nicoletti, F.
    Groc, L.
    Frick, A.
    CURRENT NEUROPHARMACOLOGY, 2014, 12 : 7 - 8
  • [34] Dysfunctions OF Metabotropic Glutamate Receptor Subtype 5 (mGlu5) Receptors in a Mouse Model of Fragile X Syndrome
    Spatuzza, M.
    Aloisi, E.
    D'Antoni, S.
    Bonaccorso, C. M.
    Molinaro, G.
    Battaglia, G.
    Musumeci, S. A.
    Davidovic, L.
    Bardoni, B.
    Ciranna, L.
    Nicoletti, F.
    Frick, A.
    Catania, M. V.
    CURRENT NEUROPHARMACOLOGY, 2014, 12 : 57 - 57
  • [35] MAVOGLURANT Metabotropic Glutamate mGlu5 Receptor Antagonist Treatment of Fragile X Syndrome Treatment of Dyskinesia
    Cole, P.
    DRUGS OF THE FUTURE, 2012, 37 (01) : 7 - 12
  • [36] Effects of mGlu1 and mGlu5 metabotropic glutamate antagonists to reverse morphine tolerance in mice
    Smith, FL
    Smith, PA
    Dewey, WL
    Javed, RR
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 492 (2-3) : 137 - 142
  • [37] Contribution of opioid and metabotropic glutamate receptor mechanisms to inhibition of bladder overactivity by tibial nerve stimulation
    Matsuta, Yosuke
    Mally, Abhijith D.
    Zhang, Fan
    Shen, Bing
    Wang, Jicheng
    Roppolo, James R.
    de Groat, William C.
    Tai, Changfeng
    AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2013, 305 (02) : R126 - R133
  • [38] SEX SPECIFIC RESPONSE OF GABAB RECEPTOR INHIBITION DURING TIBIAL AND PUDENDAL NEUROMODULATION OF BLADDER OVERACTIVITY IN CATS
    Fuller, Thomas
    Jiang, Xuewen
    Bansal, Utsav
    Lamm, Vladamir
    Shen, Bing
    Wang, Jicheng
    Roppolo, James
    DeGroat, William
    Tai, Changfeng
    JOURNAL OF UROLOGY, 2017, 197 (04): : E405 - E406
  • [39] Discovery and SAR of novel series of imidazopyrimidinones and dihydroimidazopyrimidinones as positive allosteric modulators of the metabotropic glutamate receptor 5 (mGlu5)
    Luz Martin-Martin, Maria
    Manuel Bartolome-Nebreda, Jose
    Conde-Ceide, Susana
    Alonso de Diego, Sergio A.
    Lopez, Silvia
    Martinez-Viturro, Carlos M.
    Han Min Tong
    Lavreysen, Hilde
    Macdonald, Gregor J.
    Steckler, Thomas
    Mackie, Claire
    Bridges, Thomas M.
    Daniels, J. Scott
    Niswender, Colleen M.
    Noetzel, Meredith J.
    Jones, Carrie K.
    Conn, P. Jeffrey
    Lindsley, Craig W.
    Stauffer, Shaun R.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (06) : 1310 - 1317
  • [40] Location and Cell-Type-Specific Bias of Metabotropic Glutamate Receptor, mGlu5, Negative Allosteric Modulators
    Jong, Yuh-Jiin Ivy
    Harmon, Steven K.
    O'Malley, Karen L.
    ACS CHEMICAL NEUROSCIENCE, 2019, 10 (11): : 4558 - 4570
12345